This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Companies in this article
Effective July 1, Myriad Pharmaceuticals, Inc. (Nasdaq:MYRX) will change its name to Myrexis, Inc.
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.